openPR Logo
Press release

Antidiabetics Market share to grow at 10% CAGR from 2016 to 2023

04-25-2017 11:06 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Global Market Insights, Inc.

Global Market Insights, Inc.

The research report “Antidiabetics Market Size By Product (Insulin [Rapid Acting, Long Acting, Premixed, Short Acting, Intermediate Acting], Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas, GLP-1 Agonist, Meglitinides, DPP-4 Inhibitors, SGLT-2, Thiazolodinediones), By Application (Type I Diabetes, Type II & Other), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023”, by Global Market Insights, Inc., Antidiabetics Market size was USD 51.1 billion in 2015, with global industry growth forecast of over 10% CAGR. Rising prevalence of diabetes along with penetration of insulin analogs, and oral anti-diabetic drugs should spur global insulin antidiabetics market size.

Aging and obesity are the key risk factors for diabetes, with affected population slated to exceed 360 million by 2023. Major diabetes consequences include blindness, amputations, and kidney failure, with higher risk of death. Increasing geriatric population, and rising obesity trend along with rising patient awareness levels are some pivotal drivers for industry growth. Global insulin antidiabetics market size was valued at USD 51.1 billion in 2015, with 10.9% CAGR gains likely during forecast period.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/504

A number of initiatives aimed at providing insulin and other anti-diabetic drugs to patients at a cost-effective price by establishing sophisticated healthcare reimbursement network is a key global trend. Apart from this, introduction of new high-efficiency products is also expected to boost growth.

Technology growth with products such as rapid acting, and long acting insulin analogs with higher efficacies, ultra-long acting SGLT-2 inhibitor analogs, and oral antidiabetics should further contribute to industry growth. The new insulin pen technology launch enables low-pain and convenient daily injection of insulin should also propel spur therapy sales.

Generic drug manufacturers could tap the growth opportunity due to patent expiration of major popular products by introducing low cost and effective products. Moreover, emerging regions also offer a strong platform with unmet medical needs. Growing prevalence, large diabetic patient pool, and increasing awareness levels regarding diagnosis in the emerging Asia Pacific countries are some reasons for industry growth expectations. APAC was driven by the countries Japan, China and India antidiabetics market size, estimated at USD 28 billion by 2023.

Browse key industry insights spread across 71 pages with 36 market data tables & 30 figures & charts from the report Antidiabetics Market in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/antidiabetics-market

Key insights from the report include:

• Global antidiabetics market size was USD 51.1 billion in 2015, with over 10% industry gains up to 2023.

• U.S. insulin antidiabetics market share was the largest in North America, with close to 24 million estimated diabetes patients, of which 23% remain undiagnosed. Various awareness campaigns and education programs are organized by associations and diabetes societies to raise awareness and provide information regarding diabetes management.

• However, the U.S. is maturing in terms of new product launches, due to which manufacturers are now seeking towards emerging areas in diabetes for more revenue generation.

• Europe antidiabetics market will show steady growth as well, particularly due to increase in obesity prevalence, with 10% to 50% of adult population diagnosed to be obese in 2015. Germany and UK insulin antidiabetic sales accounted for more than 50% of regional revenue.

• Asia Pacific could see 13% CAGR sales growth from 2016 to 2023, with India and China still relatively unexplored in terms of potential.

• Takeda, Merck, Boehringer Ingelheim, Oramed, Pfizer, Novo Nordisk, Eli Lilly and Sanofi Aventis, are some notable industry participants.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/504

Global Market Insights has segmented the antidiabetics industry on the basis of product, application, and region:

Global Antidiabetics Market Product Analysis (Revenue, USD Million; 2012 - 2023)

• Insulin
o Rapid Acting
o Long Acting
o Premixed
o Short Acting
o Intermediate Acting

• Other Antidiabetics
o Alpha-Glucosidase Inhibitors
o Biguanides
o Sulphonylureas
o GLP-1 Agonist
o Meglitinides
o DPP-4 Inhibitors
o SGLT-2
o Thiazolodinediones

Global Antidiabetics Market Application Analysis (Revenue, USD Million; 2012 - 2023)

• Type I
• Type II and Other Diabetes

Antidiabetics Market Regional Analysis (Revenue, USD Million, 2012 – 2023)

• North America
• Europe
• Asia Pacific
• LATAM
• MEA

Browse Related Reports:

• Precision Medicine Market Size By Technology (Big Data Analytics, Gene Sequencing, Drug Discovery, Bioinformatics, Companion Diagnostics), By Application (Oncology, CNS, Immunology, Respiratory), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Scandinavia, Italy, Japan, China, India, Singapore, Mexico, Brazil, South Africa, UAE, Qatar, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

https://www.gminsights.com/industry-analysis/precision-medicine-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antidiabetics Market share to grow at 10% CAGR from 2016 to 2023 here

News-ID: 513785 • Views: 263

More Releases from Global Market Insights, Inc.

Robust rise in the demand for personal protective equipment in the light of the …
Personal protective equipment (PPE) is one of the most crucial elements for worker safety, especially in high-risk fields such as medical. The WHO (World Health Organization) has classified PPE as a collection of protective garments worn by healthcare workers or other personnel for security against infections. According to the Research report, the global Personal Protective Equipment Market was estimated at USD 47 billion in 2018 and is expected to hit $79
Biopesticides Market 2020-2024| Top Key Players are Bayer Crop Science, Marrone …
Declining availability of arable land due to excessive use of chemical pest controlling practices in farming could drive global biopesticides market outlook over the coming years. Consumers are increasingly preferring organic and sustainable food due to growing awareness regarding harmful impacts of consuming food grown with synthetic manure and chemicals. In 2016, bioherbicides saw sales of for more than USD 100 million worldwide. The product is in high demand owing to
Explosives & Pyrotechnics Market 2020-2025 | Orica Mining Services, Incitec Pivo …
The global explosives and pyrotechnics market share has witnessed a commendable growth rate in the last few years due to the increasing mining activities, military spending, and the rising use of fireworks during festivals and events across various nations. Pyrotechnics are designed to give special effects like illumination, smoke formation, propulsion, shooting, disintegration, and sound. The pyrotechnic items are not only used for entertainment but also used in military and
Why the GaN and SiC Power Semiconductor Market Is Set To Explode? | Global Playe …
In terms of geographical expansion, GaN and SiC power semiconductor market outlook is gradually changing in the developing countries of the Asia Pacific region such as India and China. The presence of large solar facilities is the most significant factor that has increased product demand in these nations. To put things into perspective, China has more solar energy capacity - a humongous 130 gigawatts - than any other nation in

All 5 Releases


More Releases for Acting

Global Single-Acting Pneumatic Cylinders Market Research Report 2018
Global Single-Acting Pneumatic Cylinders Market 2018-2025 report conveys a far-reaching research-based investigation of the market alongside the piece of the pie, figure information, top to bottom examination, and nitty-gritty outline of the Single-Acting Pneumatic Cylinders industry concerning Global market. The Single-Acting Pneumatic Cylinders advertise report further underscores on driver and limitation factors in the Global and local dimension. Get sample copy of report : https://www.marketdensity.com/contact?ref=Sample&reportid=5859 Table of Contents 1 Single-Acting Pneumatic Cylinders Market
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Biosimilar is a medicine developed on the original biological reference product. The production process of biopharmaceuticals vary from one manufacturer to another, thus every biosimilar product is unique from the other. Biosimilar manufactures use different culture conditions, master cell lines, purification techniques, and raw materials. This in turn, helps meet the rising prevalence of diabetes due to inadequate healthcare services, rising prevalence of obesity, For instance, According to 2013 American
Drama at Aidi School: Learning through Acting
Forget about your standard classroom and enter, stage right, into the world of theatre! Mixing learning with fun, English teachers at the Aidi primary school have found an innovative way of teaching their students – through the theatre! Combining textbook material with classical plays, teachers create age-group adapted scripts for their students to perform on stage. Great literature, great music, and great performances – who knew learning could be this
Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting …
The research report states that the global and China insulin market is expected to grow at a CAGR of 6.10% between 2013 and 2019 to reach US$32.2 bn by the end of 2019, from US$19.9 bn in 2012. The global and China insulin market is segmented on the basis of mode of action and source. The modes of action seen in the insulin market are rapid-acting, long-acting, short-acting, intermediate-acting, and
Opening of Michelle Danner Los Angeles Acting School and New York Acting School
New York, USA (October 25, 2012)– The Michelle Danner Acting School in Los Angeles is expanding into New York with the opening of a new conservatory, which will offer a six and twelve-month Well Rounded Actor’s Training Intensive. The program at the Michelle Danner Acting School includes The Golden Box for actors. This world-class acting intensive is a two-day workshop that teaches the actor how to create fleshed-out and interesting characters